men's health bpc 157 BPC-157 Peptide Therapy smartmedicine #bpc157 #fda #evidencebasedmedicine Tissue Regeneration Size:15mL

men's health bpc 157 BPC-157 Peptide Therapy smartmedicine #bpc157 #fda #evidencebasedmedicine Tissue Regeneration Size:15mL

smartmedicine #bpc157 #fda #evidencebasedmedicine #orthopedics #peptides #healthcareinnovation #followthefro | Scott Sigman MD

The Billon 2025 paper introducing SLU-PP-915 (PMID 41421047) describes the parent compound SLU-PP-332 as lacking oral bioavailability — the orally active sibling SLU-PP-915 was developed because of that limitation

Tissue Regeneration

Size:15mL

The FDA's ban on BPC-157 peptide The FDA's concerns about BPC 157 center on safety considerations and the absence of comprehensive clinical trials